{
    "2018-04-26": [
        [
            {
                "time": "2018-01-03",
                "original_text": "Novo Nordisk’s Saxendra Could Witness Solid Growth in 2018",
                "features": {
                    "keywords": [
                        "Saxendra",
                        "solid growth",
                        "2018"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Novo Nordisk’s Hemophilia Segment Could See Steady 2018 Growth",
                "features": {
                    "keywords": [
                        "Hemophilia",
                        "steady growth",
                        "2018"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "Emisphere Amends License Agreement with Novo Nordisk",
                "features": {
                    "keywords": [
                        "license agreement",
                        "amends",
                        "Novo Nordisk"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "Novo Nordisk’s Victoza Could See High Growth in 2018",
                "features": {
                    "keywords": [
                        "Victoza",
                        "high growth",
                        "2018"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-07",
                "original_text": "BP Appoints Helge Lund To Succeed Carl-Henric Svanberg As Chairman",
                "features": {
                    "keywords": [
                        "BP",
                        "appoints",
                        "Helge Lund",
                        "chairman"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "energy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}